This metabolic rewiring could be crucial for inflammatory conditions where there is chronic complement activation, such as RA where sublytic MAC and increased glycolysis can contribute to inflammation (18–20, 73) and diabetes, where high levels of glucose cause glycation of CD59 with subsequent MAC activation (74). The gene discussed is CD59; the disease is rheumatoid arthritis.